489 related articles for article (PubMed ID: 14597787)
41. Excitotoxicity and new antiglutamatergic strategies in Parkinson's disease and Alzheimer's disease.
Koutsilieri E; Riederer P
Parkinsonism Relat Disord; 2007; 13 Suppl 3():S329-31. PubMed ID: 18267259
[TBL] [Abstract][Full Text] [Related]
42. A case-control study on Alzheimer's disease and exposure to anesthesia.
Gasparini M; Vanacore N; Schiaffini C; Brusa L; Panella M; Talarico G; Bruno G; Meco G; Lenzi GL
Neurol Sci; 2002 Apr; 23(1):11-4. PubMed ID: 12111615
[TBL] [Abstract][Full Text] [Related]
43. Apolipoprotein E epsilon4 allele in familial and sporadic Parkinson's disease.
Blázquez L; Otaegui D; Sáenz A; Paisán-Ruiz C; Emparanza JI; Ruiz-Martinez J; Moreno F; Martí-Massó JF; López de Munain A
Neurosci Lett; 2006 Oct; 406(3):235-9. PubMed ID: 16904828
[TBL] [Abstract][Full Text] [Related]
44. Alzheimer's disease and other neurological disorders.
Henderson VW
Climacteric; 2007 Oct; 10 Suppl 2():92-6. PubMed ID: 17882682
[TBL] [Abstract][Full Text] [Related]
45. Redox proteomics identification of oxidatively modified proteins in Alzheimer's disease brain and in vivo and in vitro models of AD centered around Abeta(1-42).
Sultana R; Perluigi M; Butterfield DA
J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Mar; 833(1):3-11. PubMed ID: 16236561
[TBL] [Abstract][Full Text] [Related]
46. Amyloid precursor protein-mediated free radicals and oxidative damage: implications for the development and progression of Alzheimer's disease.
Reddy PH
J Neurochem; 2006 Jan; 96(1):1-13. PubMed ID: 16305625
[TBL] [Abstract][Full Text] [Related]
47. Reducing mitochondrial decay with mitochondrial nutrients to delay and treat cognitive dysfunction, Alzheimer's disease, and Parkinson's disease.
Liu J; Ames BN
Nutr Neurosci; 2005 Apr; 8(2):67-89. PubMed ID: 16053240
[TBL] [Abstract][Full Text] [Related]
48. Potential Benefits of Nobiletin, A Citrus Flavonoid, against Alzheimer's Disease and Parkinson's Disease.
Nakajima A; Ohizumi Y
Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31295812
[TBL] [Abstract][Full Text] [Related]
49. Prevention of Alzheimer's disease.
Gauthier S
Ann Med Interne (Paris); 1998 Jun; 149(4):228-30. PubMed ID: 11490550
[TBL] [Abstract][Full Text] [Related]
50. NS-2330 (Neurosearch).
Thatte U
Curr Opin Investig Drugs; 2001 Nov; 2(11):1592-4. PubMed ID: 11763162
[TBL] [Abstract][Full Text] [Related]
51. Free radical mechanisms in dementia of Alzheimer type and the potential for antioxidative treatment.
Frölich L; Riederer P
Arzneimittelforschung; 1995 Mar; 45(3A):443-6. PubMed ID: 7763342
[TBL] [Abstract][Full Text] [Related]
52. Oxidative stress in Alzheimer disease: a possibility for prevention.
Bonda DJ; Wang X; Perry G; Nunomura A; Tabaton M; Zhu X; Smith MA
Neuropharmacology; 2010; 59(4-5):290-4. PubMed ID: 20394761
[TBL] [Abstract][Full Text] [Related]
53. Parkinson's disease, motoneuron disease and Alzheimer's disease: origins and interrelationship.
Calne DB; Eisen A
Adv Neurol; 1990; 53():355-60. PubMed ID: 2239477
[TBL] [Abstract][Full Text] [Related]
54. Oxidative stress: A major pathogenesis and potential therapeutic target of antioxidative agents in Parkinson's disease and Alzheimer's disease.
Jiang T; Sun Q; Chen S
Prog Neurobiol; 2016 Dec; 147():1-19. PubMed ID: 27769868
[TBL] [Abstract][Full Text] [Related]
55. [Behaviour of free radicals in Alzheimer's disease].
Terranova R; Sorace R; Romeo A; Di Mauro C; Romeo R; Luca S
Minerva Med; 2001 Dec; 92(6):405-10. PubMed ID: 11740427
[TBL] [Abstract][Full Text] [Related]
56. Nutraceuticals and their preventive or potential therapeutic value in Parkinson's disease.
Chao J; Leung Y; Wang M; Chang RC
Nutr Rev; 2012 Jul; 70(7):373-86. PubMed ID: 22747840
[TBL] [Abstract][Full Text] [Related]
57. Multiple antioxidants in the prevention and treatment of Parkinson's disease.
Prasad KN; Cole WC; Kumar B
J Am Coll Nutr; 1999 Oct; 18(5):413-23. PubMed ID: 10511322
[TBL] [Abstract][Full Text] [Related]
58. Biochemical and therapeutic effects of antioxidants in the treatment of Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis.
Di Matteo V; Esposito E
Curr Drug Targets CNS Neurol Disord; 2003 Apr; 2(2):95-107. PubMed ID: 12769802
[TBL] [Abstract][Full Text] [Related]
59. Effectiveness of the Mediterranean diet: can it help delay or prevent Alzheimer's disease?
Sofi F; Macchi C; Abbate R; Gensini GF; Casini A
J Alzheimers Dis; 2010; 20(3):795-801. PubMed ID: 20182044
[TBL] [Abstract][Full Text] [Related]
60. Knowing me, knowing you: can a knowledge of risk factors for Alzheimer's disease prove useful in understanding the pathogenesis of Parkinson's disease?
Sutherland GT; Siebert GA; Kril JJ; Mellick GD
J Alzheimers Dis; 2011; 25(3):395-415. PubMed ID: 21441655
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
